Franklin Resources’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Buy
230,072
+58,589
+34% +$1.4M ﹤0.01% 1512
2025
Q4
$4.58M Sell
171,483
-207,001
-55% -$4.95M ﹤0.01% 1434
2025
Q3
$7.01M Buy
378,484
+223,243
+144% +$5.28M ﹤0.01% 1293
2025
Q2
$3.35M Sell
155,241
-17,491
-10% -$325K ﹤0.01% 1518
2025
Q1
$2.87M Sell
172,732
-8,136
-4% -$148K ﹤0.01% 1567
2024
Q4
$3.32M Sell
180,868
-8,097
-4% -$131K ﹤0.01% 1530
2024
Q3
$2.83M Sell
188,965
-227
-0.1% -$3.79K ﹤0.01% 1603
2024
Q2
$3.07M Buy
189,192
+40,711
+27% +$657K ﹤0.01% 1536
2024
Q1
$2.75M Buy
148,481
+98,076
+195% +$2.43M ﹤0.01% 1595
2023
Q4
$1.58M Buy
50,405
+803
+2% +$19.2K ﹤0.01% 1474
2023
Q3
$1.03M Buy
49,602
+2,198
+5% +$59.7K ﹤0.01% 1611
2023
Q2
$1.14M Buy
47,404
+16,578
+54% +$368K ﹤0.01% 1595
2023
Q1
$580K Sell
30,826
-505
-2% -$9.62K ﹤0.01% 1639
2022
Q4
$499K Sell
31,331
-436
-1% -$6.82K ﹤0.01% 1700
2022
Q3
$520K Buy
31,767
+16,735
+111% +$271K ﹤0.01% 1675
2022
Q2
$212K Sell
15,032
-3,084
-17% -$57.6K ﹤0.01% 2007
2022
Q1
$439K Buy
18,116
+1,368
+8% +$33.1K ﹤0.01% 1877
2021
Q4
$391K Buy
+16,748
New +$337K ﹤0.01% 1997
2021
Q3
Sell
-711,711
Closed -$17.4M 2450
2021
Q2
$17.4M Buy
711,711
+2,047
+0.3% +$46.2K 0.01% 890
2021
Q1
$18.3M Sell
709,664
-768
-0.1% -$33.8K 0.01% 855
2020
Q4
$38M Buy
710,432
+627
+0.1% +$31.1K 0.02% 666
2020
Q3
$29.3M Buy
709,805
+33,215
+5% +$1.43M 0.01% 676
2020
Q2
$29M Hold
676,590
0.02% 654
2020
Q1
$28.6M Hold
676,590
0.02% 594
2019
Q4
$28.9M Sell
676,590
-73,200
-10% -$3.18M 0.02% 680
2019
Q3
$27M Hold
749,790
0.01% 678
2019
Q2
$20M Hold
749,790
0.01% 749
2019
Q1
$20.1M Buy
749,790
+719,396
+2,367% +$16.8M 0.01% 745
2018
Q4
$491K Buy
+30,394
New +$590K ﹤0.01% 1331
2018
Q2
Sell
-2,166,346
Closed -$48.7M 1465
2018
Q1
$48.7M Sell
2,166,346
-1,071,500
-33% -$29.7M 0.02% 543
2017
Q4
$97.5M Buy
3,237,846
+169,057
+6% +$5.41M 0.05% 371
2017
Q3
$116M Sell
3,068,789
-501,100
-14% -$16.3M 0.06% 329
2017
Q2
$99.6M Sell
3,569,889
-86,560
-2% -$2.58M 0.05% 362
2017
Q1
$126M Sell
3,656,449
-565,340
-13% -$20M 0.06% 309
2016
Q4
$122M Buy
4,221,789
+46,003
+1% +$1.22M 0.06% 297
2016
Q3
$133M Buy
4,175,786
+809,100
+24% +$27.4M 0.07% 285
2016
Q2
$109M Buy
3,366,686
+778,269
+30% +$26M 0.06% 328
2016
Q1
$72.4M Buy
2,588,417
+760,484
+42% +$16.6M 0.04% 425
2015
Q4
$65.2M Buy
1,827,933
+89,180
+5% +$3.14M 0.03% 477
2015
Q3
$57.5M Sell
1,738,753
-741,800
-30% -$30.9M 0.03% 510
2015
Q2
$104M Buy
2,480,553
+393,553
+19% +$15.2M 0.05% 381
2015
Q1
$68M Buy
2,087,000
+753,500
+57% +$25.9M 0.03% 506
2014
Q4
$42.3M Sell
1,333,500
-148,900
-10% -$4.22M 0.02% 651
2014
Q3
$36.7M Sell
1,482,400
-642,200
-30% -$15M 0.02% 697
2014
Q2
$48M Buy
2,124,600
+879,800
+71% +$18.4M 0.02% 613
2014
Q1
$30.3M Sell
1,244,800
-121,000
-9% -$3.06M 0.01% 746
2013
Q4
$34.1M Buy
1,365,800
+256,800
+23% +$6.06M 0.02% 665
2013
Q3
$30.5M Buy
1,109,000
+148,800
+15% +$3.11M 0.02% 690
2013
Q2
$17.4M Buy
+960,200
New +$13.2M 0.01% 795

Other funds holding ACAD